Image-guided Biopsy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511241011

Publication Date:

November 11, 2024

Pages:

112

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Image-guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
The global market for Image-guided Biopsy was estimated to be worth US$ 936 million in 2023 and is forecast to a readjusted size of US$ 1652.7 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Image-guided Biopsy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Image-guided Biopsy by region & country, by Type, and by Application.
The Image-guided Biopsy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Image-guided Biopsy.
Market Segmentation
By Company
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker
Segment by Type:
X- Ray
Ultrasound
Mammograpy
CT
MRI
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Image-guided Biopsy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Image-guided Biopsy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Image-guided Biopsy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Image-guided Biopsy Product Introduction
1.2 Global Image-guided Biopsy Market Size Forecast
1.3 Image-guided Biopsy Market Trends & Drivers
1.3.1 Image-guided Biopsy Industry Trends
1.3.2 Image-guided Biopsy Market Drivers & Opportunity
1.3.3 Image-guided Biopsy Market Challenges
1.3.4 Image-guided Biopsy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Image-guided Biopsy Players Revenue Ranking (2023)
2.2 Global Image-guided Biopsy Revenue by Company (2019-2024)
2.3 Key Companies Image-guided Biopsy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Image-guided Biopsy Product Offered
2.5 Key Companies Time to Begin Mass Production of Image-guided Biopsy
2.6 Image-guided Biopsy Market Competitive Analysis
2.6.1 Image-guided Biopsy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Image-guided Biopsy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Image-guided Biopsy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 X- Ray
3.1.2 Ultrasound
3.1.3 Mammograpy
3.1.4 CT
3.1.5 MRI
3.1.6 Others
3.2 Global Image-guided Biopsy Sales Value by Type
3.2.1 Global Image-guided Biopsy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Image-guided Biopsy Sales Value, by Type (2019-2030)
3.2.3 Global Image-guided Biopsy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgery Centers
4.1.3 Clinics
4.1.4 Others
4.2 Global Image-guided Biopsy Sales Value by Application
4.2.1 Global Image-guided Biopsy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Image-guided Biopsy Sales Value, by Application (2019-2030)
4.2.3 Global Image-guided Biopsy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Image-guided Biopsy Sales Value by Region
5.1.1 Global Image-guided Biopsy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Image-guided Biopsy Sales Value by Region (2019-2024)
5.1.3 Global Image-guided Biopsy Sales Value by Region (2025-2030)
5.1.4 Global Image-guided Biopsy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Image-guided Biopsy Sales Value, 2019-2030
5.2.2 North America Image-guided Biopsy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Image-guided Biopsy Sales Value, 2019-2030
5.3.2 Europe Image-guided Biopsy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Image-guided Biopsy Sales Value, 2019-2030
5.4.2 Asia Pacific Image-guided Biopsy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Image-guided Biopsy Sales Value, 2019-2030
5.5.2 South America Image-guided Biopsy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Image-guided Biopsy Sales Value, 2019-2030
5.6.2 Middle East & Africa Image-guided Biopsy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Image-guided Biopsy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Image-guided Biopsy Sales Value
6.3 United States
6.3.1 United States Image-guided Biopsy Sales Value, 2019-2030
6.3.2 United States Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Image-guided Biopsy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Image-guided Biopsy Sales Value, 2019-2030
6.4.2 Europe Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Image-guided Biopsy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Image-guided Biopsy Sales Value, 2019-2030
6.5.2 China Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Image-guided Biopsy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Image-guided Biopsy Sales Value, 2019-2030
6.6.2 Japan Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Image-guided Biopsy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Image-guided Biopsy Sales Value, 2019-2030
6.7.2 South Korea Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Image-guided Biopsy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Image-guided Biopsy Sales Value, 2019-2030
6.8.2 Southeast Asia Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Image-guided Biopsy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Image-guided Biopsy Sales Value, 2019-2030
6.9.2 India Image-guided Biopsy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Image-guided Biopsy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Koninklijke Philips
7.1.1 Koninklijke Philips Profile
7.1.2 Koninklijke Philips Main Business
7.1.3 Koninklijke Philips Image-guided Biopsy Products, Services and Solutions
7.1.4 Koninklijke Philips Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.1.5 Koninklijke Philips Recent Developments
7.2 Siemens Healthcare
7.2.1 Siemens Healthcare Profile
7.2.2 Siemens Healthcare Main Business
7.2.3 Siemens Healthcare Image-guided Biopsy Products, Services and Solutions
7.2.4 Siemens Healthcare Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.2.5 Siemens Healthcare Recent Developments
7.3 Analogic Corporation
7.3.1 Analogic Corporation Profile
7.3.2 Analogic Corporation Main Business
7.3.3 Analogic Corporation Image-guided Biopsy Products, Services and Solutions
7.3.4 Analogic Corporation Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.3.5 General Electric Recent Developments
7.4 General Electric
7.4.1 General Electric Profile
7.4.2 General Electric Main Business
7.4.3 General Electric Image-guided Biopsy Products, Services and Solutions
7.4.4 General Electric Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.4.5 General Electric Recent Developments
7.5 Varian Medical Systems
7.5.1 Varian Medical Systems Profile
7.5.2 Varian Medical Systems Main Business
7.5.3 Varian Medical Systems Image-guided Biopsy Products, Services and Solutions
7.5.4 Varian Medical Systems Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.5.5 Varian Medical Systems Recent Developments
7.6 Brainlab
7.6.1 Brainlab Profile
7.6.2 Brainlab Main Business
7.6.3 Brainlab Image-guided Biopsy Products, Services and Solutions
7.6.4 Brainlab Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.6.5 Brainlab Recent Developments
7.7 Medtronic
7.7.1 Medtronic Profile
7.7.2 Medtronic Main Business
7.7.3 Medtronic Image-guided Biopsy Products, Services and Solutions
7.7.4 Medtronic Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.7.5 Medtronic Recent Developments
7.8 Olympus Corporation
7.8.1 Olympus Corporation Profile
7.8.2 Olympus Corporation Main Business
7.8.3 Olympus Corporation Image-guided Biopsy Products, Services and Solutions
7.8.4 Olympus Corporation Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.8.5 Olympus Corporation Recent Developments
7.9 KARL STORZ Endoscopy India
7.9.1 KARL STORZ Endoscopy India Profile
7.9.2 KARL STORZ Endoscopy India Main Business
7.9.3 KARL STORZ Endoscopy India Image-guided Biopsy Products, Services and Solutions
7.9.4 KARL STORZ Endoscopy India Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.9.5 KARL STORZ Endoscopy India Recent Developments
7.10 Stryker
7.10.1 Stryker Profile
7.10.2 Stryker Main Business
7.10.3 Stryker Image-guided Biopsy Products, Services and Solutions
7.10.4 Stryker Image-guided Biopsy Revenue (US$ Million) & (2019-2024)
7.10.5 Stryker Recent Developments
8 Industry Chain Analysis
8.1 Image-guided Biopsy Industrial Chain
8.2 Image-guided Biopsy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Image-guided Biopsy Sales Model
8.5.2 Sales Channel
8.5.3 Image-guided Biopsy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂